CABA - Cabaletta Bio Inc
IEX Last Trade
5.63
-0.160 -2.842%
Share volume: 971,908
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$5.79
-0.16
-2.76%
Summary score
14%
Profitability
4%
Dept financing
11%
Liquidity
50%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2016 - 2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
2.75%
Return on assets
-5.57%
Return on sales
0%
Return on invested capital
-1008.18%
Total debt ratio
46.48%
Debt ratio change over timeo
-1%
Current Ratio
36.42%
Quick Ratio
0%
Cash Position Ratio
35.57%
Short-term ratios 2019 - 2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
2.75%
Return on assets
-5.57%
Return on sales
0%
Return on invested capital
-1008.18%
Total debt ratio
46.48%
Debt ratio change over timeo
-1%
Current Ratio
36.42%
Quick Ratio
0%
Cash Position Ratio
35.57%
Last quarter ratios 2020
The data are presented for the financials results of the last quarter.
Return on equity
-5.68%
Return on assets
-5.85%
Return on sales
0%
Return on invested capital
310.19%
Total debt ratio
2.41%
Debt ratio change over time
-0.99%
Current Ratio
41.19%
Quick Ratio
0%
Cash Position Ratio
40.23%
Performance ratios (change over 4 years) 2016 - 2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-101.12%
Return on assets
-101.15%
Return on sales
0%
Return on invested capital
-39.34%
Total debt ratio
-99.53%
Debt ratio change over time
-1%
Current Ratio
6.88%
Quick Ratio
0%
Cash Position Ratio
6.7%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CABA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 2.75% | -0.95% | 10.89% | 6.02% |
| Return on assets | -5.57% | 3.77% | 3.55% | 5.32% |
| Return on sales | 0% | 33.63% | 42.5% | 33.22% |
| Return on invested capital | -1008.18% | 5.38% | 8.18% | 11.98% |
| Profitability | 6% | 49% | 84% | 83% |
| Total debt ratio | 46.48% | 101.27% | 72.64% | 29.07% |
| Debt ratio change over time | -1% | 4.69% | 5.62% | 1.56% |
| Dept financing | 11% | 46% | 43% | 14% |
| Current Ratio | 36.42% | 2.09% | 2.2% | 3.95% |
| Quick Ratio | 0% | 1.98% | 1.91% | 3.21% |
| Cash Position Ratio | 35.57% | 1.5% | 0.68% | 1.67% |
| Liquididy | 50% | 12% | 28% | 26% |
| Short-term ratios | CABA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 2.75% | -26.47% | 18.76% | 5.16% |
| Return on assets | -5.57% | 4.51% | 3.92% | 4.18% |
| Return on sales | 0% | 37.94% | 39.67% | 29.9% |
| Return on invested capital | -1008.18% | 9.05% | 8.77% | 11.34% |
| Profitability | 4% | 69% | 91% | 74% |
| Total debt ratio | 46.48% | 111.53% | 82.97% | 24.67% |
| Debt ratio change over time | -1% | -30.17% | 7.77% | 0.57% |
| Dept financing | 10% | 25% | 44% | 7% |
| Current Ratio | 36.42% | 2.09% | 2.2% | 3.95% |
| Quick Ratio | 0% | 1.98% | 1.91% | 3.21% |
| Cash Position Ratio | 35.57% | 1.5% | 0.68% | 1.67% |
| Liquididy | 50% | 18% | 17% | 29% |